Is MOXICLAV 625MG TABLET approved by KKM / NPRA in Malaysia?

Yes, MOXICLAV 625MG TABLET is officially registered with the National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia under registration number MAL20014203AZ with status "PRODUCT APPROVED".

What are the generic alternatives for MOXICLAV 625MG TABLET in Malaysia?

There are 1 approved pharmaceutical formulations registered in Malaysia containing the same active ingredient (Clavulanic Acid), which can be compared for cost and availability.

MAL20014203AZPrescription (MAL-A)

MOXICLAV 625MG TABLET

Q: What are the active ingredients of MOXICLAV 625MG TABLET?

The active ingredients of MOXICLAV 625MG TABLET as declared to NPRA are: CLAVULANIC ACID 125MG, AMOXYCILLIN 500MG.

Generic Molecule: Clavulanic Acid

ACTIVE & APPROVEDValid till: 25 Oct 2031

NPRA Official Regulatory Summary

MOXICLAV 625MG TABLET is a KKM-approved Prescription Medicine registered under MAL number MAL20014203AZ by KOMEDIC SDN BHD. Its active ingredient is CLAVULANIC ACID 125MG, AMOXYCILLIN 500MG, manufactured by MEDOCHEMIE LTD (Factory B).

Holder (PRH)

KOMEDIC SDN BHD

Manufacturer

MEDOCHEMIE LTD (Factory B)

First Registered

25 Oct 2026

Validity

25 Oct 2031

Prescription Required (Schedule Poison)

Need a valid doctor's prescription renewal in Malaysia?

Consult Online Doctor (Telehealth)

Active Ingredients & Strength Formulation

2 Components

Active Substance / Molecule	Declared Strength / Dosage	Generic Directory
CLAVULANIC ACID	125MG	Find Brands
AMOXYCILLIN	500MG	Find Brands

Dosage values indicate declared active concentration per unit dose as registered with NPRA Malaysia.

Sole Registered Brand Formulation

This product is currently the primary or innovator formulation registered in Malaysia under Clavulanic Acid.

Malaysian KKM Security Hologram Verification

FarmaChecker & Meditag™

By Malaysian Ministry of Health (KKM) regulation, all genuine registered pharmaceuticals, health supplements (MAL-N), and traditional products (MAL-T) distributed in Malaysia must feature an official tamper-evident security hologram sticker on the physical packaging.

1. Visual Tilt Check

Tilt the box under light to view the micro-engraved KKM coat of arms and multi-layer iridescent security patterns.

2. Match MAL Number

Ensure the printed MAL code matches MAL20014203AZ exactly on label and box.

3. FarmaChecker Scan

Scan using the official FarmaChecker app on iOS / Android to authenticate serial token with NPRA servers.

If the packaging lacks a security hologram or fails the FarmaChecker scan, do not consume and report to Cawangan Penguatkuasaan Farmasi (CPF KKM).

Frequently Asked Questions & Verification Details

Is MOXICLAV 625MG TABLET approved by KKM / NPRA?

Yes. MOXICLAV 625MG TABLET is actively registered with the National Pharmaceutical Regulatory Agency under official registration number MAL20014203AZ with current status PRODUCT APPROVED. Registration was filed by KOMEDIC SDN BHD.

What are the active ingredients of MOXICLAV 625MG TABLET?

The declared active therapeutic components are: CLAVULANIC ACID 125MG, AMOXYCILLIN 500MG. Always follow dosage recommendations prescribed by a certified doctor or licensed pharmacist.

What are the registered generic alternatives in Malaysia?

In Malaysia, there are 1 registered brand formulations containing identical active ingredients (Clavulanic Acid). You can review them in the alternative brands section above or consult your community pharmacist for generic bioequivalent substitution.

Semakan status pendaftaran KKM / NPRA: MOXICLAV 625MG TABLET (MAL20014203AZ) | Pengganti ubat di Malaysia | Bahan aktif ubat & maklumat farmasi.